Related Experiment Video
Updated: Aug 6, 2026

An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
EUS-Guided Gastroenterostomy for Malignant Gastric Outlet Obstruction: Morphological Classification to Prevent Stent
Yu-Ting Kuo1,2, Chi-Ying Yang3, Jiann-Hwa Chen4
1Division of Endoscopy, Department of Integrated Diagnostics & Therapeutics, National Taiwan University Hospital, National Taiwan University, Taipei, Taiwan.
Objective:
Stent misdeployment is the most critical adverse event (AE) during endoscopic ultrasound-guided gastroenterostomy (EUS-GE). This study aimed to identify predictors of misdeployment in EUS-GE for malignant gastric outlet obstruction (mGOO).
Methods:
This multicenter observational study utilized a prospectively maintained registry of consecutive patients undergoing EUS-GE for mGOO at 13 tertiary centers in Taiwan, with mixed retrospective-prospective assessment of fluoroscopic morphology (FM) of the gastrointestinal tract near the ligament of Treitz (four types) and EUS morphology (EM) of the target bowel (three types). The primary outcome was the misdeployment. Multivariable analysis identified predictors of misdeployment and survival.
Results:
Between July 2020 and June 2025, 165 patients were enrolled. Technical and clinical success rates were 98.2% and 95.2%, respectively. Overall AE rate and misdeployment rates were 7.3% and 4.8%, respectively. Same-session endoscopic salvage succeeded in 87.5% of misdeployment cases. EM type C (cross-sectional bowel view) carried the highest misdeployment risk (33%) and was the sole independent predictor (adjusted odds ratio 16.9; p = 0.001). FM provided essential complementary risk stratification; FM type II was more common among misdeployment cases (25.0% vs. 3.8%; p = 0.030). Implementation of a stepwise strategy in 2023-prioritizing EM type A/B, avoiding type C, and minimizing stomach-bowel distance-resulted in zero misdeployment. Independent predictors of poor survival included pancreatic cancer, malnutrition, poor performance status, ascites, metastasis, and misdeployment.
Conclusion:
Stent misdeployment is a significant complication adversely impacting survival. Utilizing integrated EM and FM risk stratification within a stepwise strategy can minimize misdeployment and optimize clinical outcomes.
Trial Registration:
ClinicalTrials.gov: NCT07230665.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Pyloric Obstruction
Esophageal Strictures-I: Introduction
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...